Cure­Vac founder back at the helm; Mer­ck ex­tends im­munomod­u­la­to­ry drug dis­cov­ery pro­gram with Sutro

→ Daniel Menichel­la, the CEO of Cure­Vac and the face of its re­cent en­deav­ors to de­vel­op an mR­NA vac­cine against Covid-19, is step­ping down. Founder In­g­mar Ho­err is back in charge; the tran­si­tion hap­pens just days af­ter Menichel­la at­tend­ed the high-pro­file White House coro­n­avirus R&D meet­ing along­side oth­er bio­phar­ma ex­ecs. While Ho­err thanked Menichel­la for “his lead­er­ship hav­ing built a ter­rif­ic glob­al team” and ex­tolled the pipeline that he left be­hind, no rea­son was giv­en for the sud­den de­par­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER